Replies to post #685266 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

When applying for a marketing approval, an immunology company needs to provide manufacturing information to the UK regulatory authorities. The manufacturing information is important for assessing the quality, safety, and efficacy of the immunology product. It helps regulatory authorities ensure that the manufacturing process meets the necessary standards and that the product is consistently produced to the required specifications. Providing manufacturing information is a crucial part of the regulatory approval process to ensure that the immunology product meets all the necessary regulatory requirements. — Chat GPT

Just so you know what is quoted below is BS.

I have reasons to think that the plan has been to start commercial manufacturing with the automated Flaskworks process…. — Hyperopia

The wording of the Flaskworks PR leads me think they are attempting to time it, (aka Eden manufacturing) “upon (DCVax-l) approval….” — Senti

[manibiotech]

They are most likely preparing the disciples in case there is a delay , so that they believe that the delay was for their own good .